Hilleman Laboratories has today announced that its partner Bharat Biotech, has successfully launched HILLCHOL®, a breakthrough oral cholera vaccine (OCV), achieving a significant global public health milestone. Continue reading
Jan. 4, 2024 /Health/ — The recent outbreaks of Cholera, Typhoid, dysentery, syphilis, and Anthrax in Zambia are concerning and raise questions about the effectiveness of the Zambia health service and the need for transparency in data. Here’s a breakdown of the situation and potential explanations: Continue reading